Introduction
Nitric oxide (NO),' a radical produced in mammalian cells from arginine in a reaction catalyzed by nitric oxide synthase (NOS), has pleiotropic biologic activities (1) (2) (3) . NO is produced during inflammatory reactions and has been implicated as a signaling molecule (4-6) as well as a toxic effector (7) (8) (9) (10) . NO mediates activation or inhibition of various enzyme systems (6, 11) , DNA damage (12-15), and oxidative reactions (16-21), with a variety of biologic effects, including killing of microorganisms (22) , antiviral activity (23) , and cytostasis and cell death (2, 3, (7) (8) (9) (10) 24) .
Expression of the inducible form of NOS (25, 26 ) is regulated by cytokines, including IFN-y and TNF-a. TNF-a and IFN-y enhance expression of inducible NOS (iNOS) and NO production in a variety of cell types (27) (28) (29) (30) (31) . The promoter region of iNOS contains several sequences that potentially bind IFN-y-induced transcription factors, including an interferon regulatory factor-i (IRF-1) binding element (32, 33) . induced by IFN-y binds to the promoter region of the iNOS gene (34) and enhances iNOS mRNA expression (33, 34) . A different activation pathway involving NF-KB/Rel that has been proposed for LPS may also operate for TNF-a-mediated induction of iNOS (35) . Because some of the biologic effects of IFN-y and TNF-a are similar to those described for NO, they may be due to cytokine-mediated induction of NO in the target cells.
A pathophysiologic role of NO has been proposed for several autoimmune diseases (7) (8) (9) 36) . TNF-a and IFN-y suppress hematopoietic progenitor cell proliferation (37) (38) (39) (40) and have been implicated in the mechanism of bone marrow (BM) failure (41) (42) (43) (44) (45) (46) (47) (48) . In aplastic anemia, aberrant production of IFN-'y (42, 43) and upregulation of TNF-P (44) in normal human bone marrow likely induce apoptosis of hematopoietic stem cells and progenitor cells. IFN-y and TNF-a suppress both early and late stages of hematopoiesis and induce programmed cell death (C. Selleri, S. Anderson, N. Young, and J. Maciejewski, manuscript submitted for publication). Involvement of IFNy and TNF-a in the regulation of NO production suggested that NO may influence the function of BM and may be relevant for understanding the pathophysiology of hematologic diseases.
Methods BM cell preparation. BM was obtained from healthy volunteers by aspiration from the posterior iliac crest into syringes containing Iscove's modified Dulbecco's medium (IMDM; GIBCO BRL, Gaithersburg, MD) supplemented 1:10 with preservative-free heparin (O'Neill and Feldman, St. Louis, MO). Informed consent was obtained according to a protocol approved by the Institutional Review Board of the National Heart, Lung, and Blood Institute. Mononuclear BM cells were isolated by density gradient centrifugation using lymphocyte separation medium (Organon, Durham, NC). After washing in HBSS (GIBCO BRL), cells were resuspended in IMDM supplemented with 20% FCS (GIBCO BRL).
Separation of CD34 + cells. CD34 + cells were separated using affinity chromatography (Cellpro, Bothell, WA) and flow cytometry. Briefly, nonadherent BM cells were incubated at room temperature with murine anti-human CD34 IgM, washed in PBS, and incubated with streptavidin-conjugated goat F(ab')2 anti-mouse IgM. After washing with PBS supplemented with 2% human albumin, cells were applied to an affinity column containing biotin-coated beads, and the CD34+ cell fraction was eluted with PBS. An aliquot of the eluted cells was stained with phycoerythrin-conjugated anti-CD34 HPCA-2 monoclonal antibody (Becton Dickinson, Mountain View, CA) to assess the purity of the eluted cells. Usually, 70-90% of separated cells were CD34'. For higher purity preparations, cells were further fractionated; column-purified cells were stained with FITC-labeled anti-CD34+ mAb (Becton Dickinson), washed with PBS, and sorted by microfluorometry (Epics V; Coulter, Hialeah, FL). The purity of cells obtained by combining affinity chromatography and flow cytometry was 97-99%.
Hematopoietic cell culture. For short-term suspension cultures, CD34+ BM cells were cultured in 96 round-bottom well plates at a density of 5 x 104 cells/ml (1 x 104 cells/well) in medium consisting of IMDM, 20% FCS, 50 ng/ml IL-3 (Genzyme, Boston, MA), 50 ng/ml stem cell factor (Amgen, Thousand Oaks, CA), and 2 U/ml erythropoietin ( (54) . High molecular weight DNA was precipitated for 6 h in the presence of 5 M NaCl. The high molecular weight fraction was pelleted by high-speed centrifugation, and the fragmented DNA was extracted from the aqueous phase with phenol and chloroform and then precipitated with ethanol. After resuspension in water, DNA was electrophoresed using 1.5% agarose gel and visualized by ethidium bromide staining.
To quantitate the number of cells undergoing apoptosis, cells were harvested, fixed with 4% neutral buffered formalin, and cytocentrifuged onto siliconized slides. Apoptotic cells were stained using the terminal deoxynucleotidyl transferase (TdT) method (Apotag; Oncor, Gaithersburg, MD). Endogenous peroxidase was first quenched with 0.5% hydrogen peroxide, and the cells were permeabilized using company-supplied equilibration buffer. The 3' OH ends of degraded DNA were reacted with TdT and digoxygenin-labeled ATP for 30 min. After washing with PBS, slides were reacted with an anti-digoxygenin mAb conjugated to peroxidase, washed, and developed with 3,3 '-diaminobenzidine tetrahydrochloride (Pierce, Rockford, IL). Stained cells were counted using a light microscope.
Reverse transcription PCR for human iNOS. Total RNA was extracted from constant numbers of mononuclear marrow cells and CD34 + cells using RNAsol (Cinna/Biotecx, Friendswood, TX). Contaminating DNA was digested using RNase-free DNaseI (Boehringer Mannheim). RNA was reextracted with phenol and chloroform, precipitated with ethanol, and diluted in RNase-free water. After reverse transcription using oligo(dT)16 primer, iNOS cDNA was amplified using primers 5' CGGTGCTGTATTY CCTTACGAGGCGAAGAAGG 3' and 5' GGT-GCTGCTTGTTAGGAGGTCAAGTAAAGGGC 3' specific for iNOS and primers specific for human /3-actin. The PCR products were electrophoresed on 1.2% agarose gels and transferred onto nytran filters (Schleicher & Schuell, Keene, NH). The blots were then hybridized with an internal oligonucleotide 5' labeled with 32p using T4-kinase (Boehringer Mannheim). After washing under stringent conditions (0.1 x SSC, 0.5% SDS), membranes were exposed to x-ray film and developed.
Immunocytochemical staining and immunoprecipitation. BM cells were starved for 2 h in methionine-and cysteine-deficient medium containing 2% dialysed FCS, washed, and resuspended in the medium containing 2 uCi/ml of [35S] methionine and cysteine (Trans-label; ICN Biomedicals, Irvine, CA). Total BM cells were cultured for 24 h in the presence of TNF-a or IFN-y, lysed in radioimmunoprecipitation buffer, and, after addition of mouse serum, cleared for 2 h with protein-A agarose (Boehringer Mannheim). After overnight incubation with 2 jg of mouse anti-mouse iNOS peptide 961-1144 monoclonal IgG with cross-reactivity to human iNOS (Transduction Laboratories, Lexington, KY), cell lysates were incubated with rabbit anti-mouse IgG (Pierce) for 2 h and reacted with 30 p1 protein-A agarose suspension for 2 h. After multiple washing steps, agarose-bound complexes were denatured by boiling in loading buffer containing 1% mercaptoethanol, electrophoresed on 8% SDS-polyacrylamide, and either transferred onto nitrocellulose membranes (Novex, San Diego, CA) or vacuum-dried and exposed to x-ray film. After blocking for 2 h (Superblock; Pierce), blots were reacted with 2 pg of mouse anti-iNOS mAb (Transduction Laboratories) over night and developed with alkaline-phosphatase-conjugated rabbit anti-mouse IgG (Pierce) for 2 h. Bands of 130 kD corresponded to the human iNOS.
For immunocytochemistry, cultured purified CD34 + cells were washed in PBS and cytocentrifuged onto siliconized slides. After fixation with ice-cold 50:50 methanol/acetone for 10 min, slides were blocked with PBS-containing 10% normal goat serum, reacted with rabbit anti-human iNOS peptide IgG purified from antiserum (kindly provided by Merck Research Laboratories, West Point, PA) and developed with Texas red-conjugated goat anti-rabbit IgG (Vector Lab, Burlingame, CA). Immunizing peptide was used to block anti-human iNOS polypeptide IgG. As positive controls, 293 cells transfected with human iNOS cDNA were used (25 throid cells decreased in colony-forming ability ( Fig. 1 A) . To exclude the possibility that the inhibition of colony formation was due to the carrier molecule, DETA, or to nitrite generated in the medium from released NO, both substances were added to the culture as controls. No effect on colony formation was observed with DETA and nitrite used at appropriate concentrations ( Fig. 1 B) . The inhibitory effect of NO was dose dependent. The presence of accessory cells was not required for DETA/NO suppression. The CD34' cell population used in this experiment includes committed and primitive progenitor cells (55, 56) . NO-mediated hematopoietic inhibition is associated with the induction of apoptosis of BM cells. The observed suppression of colony formation by NO could be due to a reversible inhibition of progenitor cell cycling without loss of viability or to the induction of cell death. Analysis of low molecular weight DNA extracted from total BM cultured in suspension in the presence of the NO-releasing compound DETA/NO showed a nucleosomal DNA degradation pattern on agarose gels stained with ethidium bromide characteristic of apoptosis (Fig. 2) (Fig. 4 B) . Because the iNOS signal in total BM cells might be due to the presence of accessory cells, we tested whether more immature cells contained in the CD34 + cell population expressed iNOS. To minimize the possibility of contamination with mature cells potentially expressing iNOS, we used preparations containing 98% CD34+ cells. Simultaneous staining with CD14 mAb, specific for monocytes and macrophages, and anti-CD2 mAb for lymphocytes, showed less than 3% of CD14+ and 2% of CD2+ cells in CD34+ cell preparations used for PCR. iNOS mRNA was detectable in the CD34 + cells cultured for 24 h in medium alone, and IFN-y-or TNF-astimulated cells showed a stronger amplification signal (Fig. 4  A) . Immunocytochemical staining with human iNOS-specific antiserum of CD34+ cells confirmed the presence of iNOS protein at the single cell level in freshly purified CD34 + cells from some donors. The presence of iNOS protein in a proportion of cultured CD34+ cells was consistent with the PCR results, with low untreated and cytokine-enhanced expression of iNOS in CD34 + cells (Fig. 4, C and D) . To determine if more immature progenitors, defined by the expression of CD38 antigen, contained iNOS mRNA, we sorted CD34+CD38 wh (Fig. 5 A) and CD34+CD38d'- (Fig. 5 B) cells and performed RT-PCR on both cell fractions. Human iNOS mRNA was detectable both in less mature CD34+CD38am and in mature CD34+CD38"'gh BM cells (Fig. 5 C) . Effects of inhibition of iNOS on the proliferation of BM progenitors. Because NO inhibited hematopoietic colony formation and IFN-y and/or TNF-a increased the expression of iNOS in BM progenitors, we tested whether the inhibitory effects of these cytokines were related to NO production. Addition of MM-Arg, a competitive inhibitor of iNOS, to methylcellulose cultures of total BM cells partially reversed the suppressive effects of IFN-y and/or TNF-a on colony growth (Table I) . MM-Arg showed more pronounced effects on cultures that included TNF-a. Parallel results were obtained in colony cultures from CD34+ cells (Table I) . Similar degrees of inhibition by IFN-y and TNF-a were observed for both erythroid and myeloid series. Within myeloid subsets combining granulocytic, macrophage, and granulocytic-monocytic colonies, preferential survival of macrophage colonies after IFN-y and TNF-a was seen in both total and CD34 + cell cultures. In cultures supplemented with MM-Arg, granulocytic, macrophage, and granulocyticmonocytic colonies were represented at similar proportions as in control cultures (data not shown).
In suspension cultures of total BM and purified CD34+ cells, MM-Arg also partially prevented IFN-y-and TNF-ainduced apoptosis (Fig. 6) .
To determine whether cytokine-mediated NO production showed differential inhibitory effects on Although the presence of MM-Arg in LTBMC increased the total output of CFU in cultures not treated with WFN-y and TNF-a, cytokine-suppression of LTCIC survival was unaffected (Table II) . Similar to the primary methylcellulose assay, surviving myeloid colony-forming cells in IFN--y and TNF-a were predominantly of the macrophage type (data not shown).
Discussion
We studied cytokine pathways leading to the induction of NO production and NO effects on human hematopoiesis in vitro. NO decreased colony formation by total human BM and purified CD34' cell preparations, demonstrating that the effects of NO were direct with regard to a cell population containing hematopoietic progenitor cells (55, 56) . The detection of apoptosis in these experiments, in both total BM and CD34 + cells, suggests that the suppressive effects of NO may be at least partially attributed to irreversible cytotoxicity. In the presence of IFN-y and/or TNF-a, iNOS expression appeared to be enhanced not only in total BM containing mature accessory cells but also in the immature cells defined by the CD34 surface antigen. Although in isolated CD34+ cells the expression of iNOS showed some variability, there was a concordance between iNOS expression and the presence of cytokines in culture in both iNOSspecific RT-PCR and immunocytochemistry performed on 
